New York AG’s Inquiry Into Pharmaceutical Trading Practices Continues Following Cardinal Settlement
This article was originally published in The Pink Sheet Daily
Executive Summary
As part of the agreement, the firm is required to enter “Wholesaler Safe Product Practice” agreement.
You may also be interested in...
AmerisourceBergen To Purchase All Drugs Directly From Manufacturers
The wholesaler currently buys less than 0.5% of U.S-distributed drugs from the secondary wholesale market.
N.Y. Attorney General Seeks Information On Wholesaler Deals With Secondary Market
Pharmaceutical wholesalers including Cardinal, ABC are subpoenaed by AG Eliot Spitzer's office in an inquiry into the wholesale secondary market, which has been associated with counterfeiting. The three top wholesalers have previously stated their intentions to cut back on secondary purchases.
Celgene To Submit Revlimid Phase III Special Protocol Assessment For CLL To FDA Shortly
Firm notes strong uptake of the product in 2006, as well as more than $400 million in Thalomid sales for the year during earnings call.